T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$4.95B |
| 2 |
Broadcom
AVGO
|
+$3.48B |
| 3 |
Microsoft
MSFT
|
+$2.66B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.92B |
| 5 |
GE Aerospace
GE
|
+$1.49B |
Top Sells
| 1 |
Amazon
AMZN
|
+$3.79B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.63B |
| 3 |
Apple
AAPL
|
+$2.46B |
| 4 |
Fiserv
FI
|
+$2.19B |
| 5 |
Eli Lilly
LLY
|
+$1.78B |
Sector Composition
| 1 | Technology | 34.76% |
| 2 | Financials | 12.08% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Trinseo
TSE
$81.6M
| $127K | ﹤0.01% |
40,483
+16,583
| +69% | +$52K |
|
2827
Vanda Pharmaceuticals
VNDA
$265M
| $127K | ﹤0.01% |
26,765
| – | – |
|
2828
Satellogic
SATL
$374M
| $126K | ﹤0.01% |
+34,579
| New | +$126K |
|
2829
Abeona Therapeutics
ABEO
$335M
| $125K | ﹤0.01% |
+21,909
| New | +$125K |
|
2830
SkyWater Technology
SKYT
$474M
| $124K | ﹤0.01% |
12,556
+321
| +3% | +$3.17K |
|
|
CHMI
2831
Cherry Hill Mortgage Investment Corp
CHMI
$107M
| $123K | ﹤0.01% |
44,762
| – | – |
|
2832
Compass Therapeutics
CMPX
$604M
| $123K | ﹤0.01% |
46,942
| – | – |
|
2833
Ironwood Pharmaceuticals
IRWD
$187M
| $123K | ﹤0.01% |
172,521
+1,243
| +0.7% | +$886 |
|
2834
The ONE Group
STKS
$82.3M
| $123K | ﹤0.01% |
30,305
-8,485
| -22% | -$34.4K |
|
2835
American Coastal Insurance
ACIC
$526M
| $122K | ﹤0.01% |
10,957
| – | – |
|
|
SRTA
2836
Strata Critical Medical, Inc. Class A Common Stock
SRTA
$326M
| $122K | ﹤0.01% |
30,150
+5,342
| +22% | +$21.6K |
|
|
KGEI
2837
Kolibri Global Energy
KGEI
$191M
| $122K | ﹤0.01% |
+17,699
| New | +$122K |
|
2838
Mammoth Energy Services
TUSK
$113M
| $122K | ﹤0.01% |
43,285
+16,812
| +64% | +$47.4K |
|
2839
Oportun Financial
OPRT
$283M
| $121K | ﹤0.01% |
+16,796
| New | +$121K |
|
2840
Organogenesis Holdings
ORGO
$617M
| $121K | ﹤0.01% |
32,889
+3,997
| +14% | +$14.7K |
|
2841
Gossamer Bio
GOSS
$707M
| $118K | ﹤0.01% |
95,291
+30,514
| +47% | +$37.8K |
|
2842
Editas Medicine
EDIT
$230M
| $117K | ﹤0.01% |
53,137
+9,360
| +21% | +$20.6K |
|
2843
Viemed Healthcare
VMD
$256M
| $117K | ﹤0.01% |
16,901
+2,141
| +15% | +$14.8K |
|
2844
Astria Therapeutics
ATXS
$423M
| $116K | ﹤0.01% |
21,517
+1,327
| +7% | +$7.15K |
|
2845
Blue Ridge Bankshares
BRBS
$380M
| $116K | ﹤0.01% |
+32,261
| New | +$116K |
|
2846
Savers
SVV
$1.97B
| $116K | ﹤0.01% |
+11,351
| New | +$116K |
|
2847
Tyra Biosciences
TYRA
$635M
| $116K | ﹤0.01% |
+12,022
| New | +$116K |
|
2848
Krispy Kreme
DNUT
$514M
| $115K | ﹤0.01% |
39,321
+1,507
| +4% | +$4.41K |
|
2849
Tredegar Corp
TG
$271M
| $115K | ﹤0.01% |
12,988
+519
| +4% | +$4.6K |
|
2850
Target Hospitality
TH
$876M
| $115K | ﹤0.01% |
16,103
+1,966
| +14% | +$14K |
|